Approach to relapsed CLL including Richter Transformation

被引：2
|
作者：
Seymour, John F. [1 ,2 ]
机构：
[1] Univ Melbourne, Royal Melbourne Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] Peter MacCallum Canc Ctr, Dept Haematol, 305 Grattan St, Melbourne, VIC 3000, Australia
来源：
HEMATOLOGICAL ONCOLOGY | 2023年 / 41卷
关键词：
acalabrutinib; chronic lymphocytic leukemia; ibrutinib; relapse; Richter transformation; treatment sequencing; Venetoclax; zanubrutinib; CHRONIC LYMPHOCYTIC-LEUKEMIA; VENETOCLAX PLUS RITUXIMAB; OPEN-LABEL; MUTATIONS; MECHANISMS; IDELALISIB; RESISTANCE; SURVIVAL; EFFICACY; THERAPY;
D O I：
10.1002/hon.3146
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：136 / 143
页数：8
相关论文
共 50 条
  • [31] Cytogenomic features of Richter transformation
    Renata Woroniecka
    Grzegorz Rymkiewicz
    Zbigniew Bystydzienski
    Barbara Pienkowska-Grela
    Jolanta Rygier
    Natalia Malawska
    Katarzyna Wojtkowska
    Nikolina Goral
    Katarzyna Blachnio
    Marcin Chmielewski
    Magdalena Bartnik-Glaska
    Beata Grygalewicz
    Molecular Cytogenetics, 16
  • [32] Biology and Treatment of Richter Transformation
    Condoluci, Adalgisa
    Rossi, Davide
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [33] Cytogenomic features of Richter transformation
    Woroniecka, Renata
    Rymkiewicz, Grzegorz
    Bystydzienski, Zbigniew
    Pienkowska-Grela, Barbara
    Rygier, Jolanta
    Malawska, Natalia
    Wojtkowska, Katarzyna
    Goral, Nikolina
    Blachnio, Katarzyna
    Chmielewski, Marcin
    Bartnik-Glaska, Magdalena
    Grygalewicz, Beata
    MOLECULAR CYTOGENETICS, 2023, 16 (01)
  • [34] Update on the role of venetoclax and rituximab in the treatment of relapsed or refractory CLL
    D'Rozario, James
    Bennett, Samuel K.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10 : 1 - 12
  • [35] Hodgkin's Variant of Richter Transformation in Chronic Lymphocytic Leukemia; A Retrospective Study from the Israeli CLL Study Group
    Tadmor, Tamar
    Shvidel, Lev
    Goldschmidt, Neta
    Ruchlemer, Rosa
    Fineman, Riva
    Bairey, Osnat
    Rahimi-Levene, Naomi
    Herishanu, Yair
    Yuklea, Mona
    Arad, Ariela
    Aviv, Ariel
    Polliack, Aaron
    ANTICANCER RESEARCH, 2014, 34 (02) : 785 - 790
  • [36] Richter Transformation Arising From Chronic Lymphocytic Leukemia
    Rogers, Barbara Barnes
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2022, 26 (01) : 14 - 17
  • [37] Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel in patients with relapsed/refractory CLL or SLL
    Siddiqi, Tanya
    Soumerai, Jacob D.
    Dorritie, Kathleen A.
    Stephens, Deborah M.
    Riedell, Peter A.
    Arnason, Jon
    Kipps, Thomas J.
    Gillenwater, Heidi H.
    Gong, Lucy
    Yang, Lin
    Ogasawara, Ken
    Thorpe, Jerill
    Wierda, William G.
    BLOOD, 2022, 139 (12) : 1794 - 1806
  • [38] Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor-resistant chronic lymphocytic leukemia with disease progression and Richter transformation
    Kanagal-Shamanna, Rashmi
    Jain, Preetesh
    Patel, Keyur P.
    Routbort, Mark
    Bueso-Ramos, Carlos
    Alhalouli, Tahani
    Khoury, Joseph D.
    Luthra, Rajyalakshmi
    Ferrajoli, Alessandra
    Keating, Michael
    Jain, Nitin
    Burger, Jan
    Estrov, Zeev
    Wierda, William
    Kantarjian, Hagop M.
    Medeiros, L. Jeffrey
    CANCER, 2019, 125 (04) : 559 - 574
  • [39] The STELLAR trial protocol: a prospective multicentre trial for Richter's syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease
    Appleby, Niamh
    Eyre, Toby A.
    Cabes, Maite
    Jackson, Aimee
    Boucher, Rebecca
    Yates, Francesca
    Fox, Sonia
    Rawstron, Andrew
    Hillmen, Peter
    Schuh, Anna
    BMC CANCER, 2019, 19 (1)
  • [40] In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities
    ten Hacken, Elisa
    Sewastianik, Tomasz
    Yin, Shanye
    Hoffmann, Gabriela Brunsting
    Gruber, Michaela
    Clement, Kendell
    Penter, Livius
    Redd, Robert A.
    Ruthen, Neil
    Hergalant, Sebastien
    Sholokhova, Alanna
    Fell, Geoffrey
    Parry, Erin M.
    Broseus, Julien
    Guieze, Romain
    Lucas, Fabienne
    Hernandez-Sanchez, Maria
    Baranowski, Kaitlyn
    Southard, Jackson
    Joyal, Heather
    Billington, Leah
    Regis, Fara Faye D.
    Witten, Elizabeth
    Uduman, Mohamed
    Knisbacher, Binyamin A.
    Li, Shuqiang
    Lyu, Haoxiang
    Vaisitti, Tiziana
    Deaglio, Silvia
    Inghirami, Giorgio
    Feugier, Pierre
    Stilgenbauer, Stephan
    Tausch, Eugen
    Davids, Matthew S.
    Getz, Gad
    Livak, Kenneth J.
    Bozic, Ivana
    Neuberg, Donna S.
    Carrasco, Ruben D.
    Wu, Catherine J.
    BLOOD CANCER DISCOVERY, 2023, 4 (02): : 150 - 169
12345